Literature DB >> 8112859

Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice.

C K Lee1, R Weltzin, G Soman, K M Georgakopoulos, D M Houle, T P Monath.   

Abstract

A simple animal model was used to demonstrate passive protection by immunoglobulin A (IgA) against a mucosal pathogen, Vibrio cholerae. Oral administration of a monoclonal IgA directed against a lipopolysaccharide component of the vibrio protected neonatal mice against oral challenge, as measured by reduced intestinal colonization. A single dose of 0.1 microgram of polymeric monoclonal IgA given 1 h prior to challenge reduced the number of recoverable vibrios by at least 100-fold. An additional dose 3 h before challenge or 1 h after challenge did not enhance protection. A 10-fold-higher concentration of monomeric IgA was required to achieve the same level of protection as that conferred by polymeric IgA. Polymeric IgA digested with trypsin or human duodenal aspirates to lower-molecular-weight fragments retained most of its ability to protect mice against challenge.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112859      PMCID: PMC186198          DOI: 10.1128/iai.62.3.887-891.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Automatic analysis of tissue culture proteins with stable Folin reagents.

Authors:  B ZAK; J COHEN
Journal:  Clin Chim Acta       Date:  1961-09       Impact factor: 3.786

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Studies on the structural and conformational basis for the relative resistance of serum and secretory immunoglobulin A to proteolysis.

Authors:  B J Underdown; K J Dorrington
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

4.  Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies.

Authors:  R Freter; P C O'Brien; M S Macsai
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

5.  New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.

Authors:  L Winner; J Mack; R Weltzin; J J Mekalanos; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 6.  Mechanisms of disease and immunity in cholera: a review.

Authors:  J Holmgren; A M Svennerholm
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

7.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

Authors:  R K Taylor; V L Miller; D B Furlong; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa.

Authors:  D S Chitnis; K D Sharma; R S Kamat
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

9.  Antibacterial and antitoxin responses in the serum and milk of cholera patients.

Authors:  A S Majumdar; P Dutta; D Dutta; A C Ghose
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Evaluation of the biological properties of different classes of human antibodies in relation to cholera.

Authors:  A S Majumdar; A C Ghose
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

View more
  7 in total

1.  Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology.

Authors:  P Crottet; S Cottet; B Corthésy
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

2.  In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells.

Authors:  J Berdoz; C T Blanc; M Reinhardt; J P Kraehenbuhl; B Corthésy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Purification and characterization of novel hemagglutinins from Vibrio mimicus: a 39-kilodalton major outer membrane protein and lipopolysaccharide.

Authors:  M Alam; S I Miyoshi; K I Tomochika; S Shinoda
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Ingested allergens must be absorbed systemically to induce systemic anaphylaxis.

Authors:  Richard T Strait; Ashley Mahler; Simon Hogan; Marat Khodoun; Akira Shibuya; Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2011-02-26       Impact factor: 10.793

5.  Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

Authors:  R Weltzin; S A Hsu; E S Mittler; K Georgakopoulos; T P Monath
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

6.  In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae.

Authors:  Ana Paula Galvão da Silva; Donovan Unks; Shu-chen Lyu; Jeffrey Ma; Renata Zbozien-Pacamaj; Xi Chen; Alan M Krensky; Carol Clayberger
Journal:  J Antimicrob Chemother       Date:  2008-02-29       Impact factor: 5.790

7.  Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis.

Authors:  A Phalipon; M Kaufmann; P Michetti; J M Cavaillon; M Huerre; P Sansonetti; J P Kraehenbuhl
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.